[EN] FUSED BICYCLIC PYRROLE AND IMIDAZOLE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE PYRROLE ET D'IMIDAZOLE BICYCLIQUES CONDENSÉS EN TANT QU'INHIBITEURS DE KINASE
申请人:UCB PHARMA SA
公开号:WO2011058109A1
公开(公告)日:2011-05-19
A series of substituted pyrrolo[2,1-ƒ][1,2,4]triazine and imidazo[2,1-ƒ]-[1,2,4]triazine derivatives, and fused pyridazine analogues thereof, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions (Formula (I)).
一系列取代的
吡咯并[2,1-ƒ]
[1,2,4]三嗪和
咪唑并[2,1-ƒ]-
[1,2,4]三嗪衍
生物,以及融合的
吡啶嗪类似物,是选择性
PI3激酶酶
抑制剂,在医学上具有益处,例如在治疗炎症性、自身免疫、心血管、神经退行性、代谢性、肿瘤、疼痛或眼科疾病方面(
化学式(I))。